A carregar...

FXR activation by obeticholic acid elevates liver LDL receptor expression by mRNA stabilization and reduces plasma LDL-cholesterol in mice

OBJECTIVE: To determine whether and how activation of farnesoid X receptor (FXR) by obeticholic acid (OCA), a clinical FXR agonist, modulates liver LDL receptor (LDLR) expression under normolipidemic conditions. APPROACH AND RESULTS: Administration of OCA to chow-fed mice increased mRNA and protein...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arterioscler Thromb Vasc Biol
Main Authors: Singh, Amar Bahadur, Dong, Bin, Kraemer, Fredric B., Xu, Yanyong, Zhang, Yanqiao, Liu, Jingwen
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206879/
https://ncbi.nlm.nih.gov/pubmed/30354208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.118.311122
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!